Amid Growing Concern over the New #Covid Variant Omicron, #Hyderabad-based Vaccine ... - Latest Tweet by IANS India

Amid growing concern over the new #Covid variant Omicron, #Hyderabad-based vaccine manufacturer #BharatBiotech's #Covaxin on Saturday got approval from the Drug Controller General of India (DGCI) for emergency use for children aged between 12-18 years. pic.twitter.com/siHptXb2X0— IANS Tweets (@ians_india) December 25, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)